News
Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...
The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback